King Pharmaceuticals

October 12, 2010 by staff 

King Pharmaceuticals, Stock futures were pointing to a lower opening as traders await the release of the minutes of the meeting of the Federal Reserve in September and ahead of earnings from Intel Corp. barometer after the closing bell.

Here are some precursors such as the market Tuesday.

The insurance company of digital identity has announced that it would be acquired by Swedish lock maker Assa Abloy 162 million and sent sent soaring by 42.5% in premarket trading.

King Pharmaceuticals (NYSE: KG)

Shares of pharmaceutical company jumped 39.1% in the pre-market trading after announcing that it would be acquired by Pfizer and 14.25 per share in a transaction valued at 3.6 billion.

Geron Corp. (Nasdaq: GERN)

Shares of the biopharmaceutical company, rose 4.4% in pre-market trading Tuesday after announcing late Monday that the first human trial of its treatment on embryonic stem cells had begun.

Global Payments Inc. (NYSE: GPN)

The company’s electronic payment transactions posted first-quarter results below expectations reporting a profit of 61 cents per share on revenue of 440.1 million and. Analysts had estimated earnings of 69 cents per share and revenue of 438.6 million and. Shares plunged 13.2% in premarket trading.

Tongxin International Ltd. (NASDAQ: TXIC)

Chinese carmaker body said it had received notification from NASDAQ that is no longer in compliance with registration after failing to file a Form 20-F, a requirement for foreign listings. The shares were down 12.2% in premarket trading.

Synaptics Inc. (NASDAQ: SYNA)

After the close Monday, the UI developer lowered its forecast for quarterly earnings and announced the resignation of its CEO by sending down 6.1% in pre-market trading Tuesday.

Report to Team

Please feel free to send if you have any questions regarding this post , you can contact on

Disclaimer: The views expressed on this site are that of the authors and not necessarily that of U.S.S.POST.


Comments are closed.